Accelerators · United States
4 programmes. Of these, 2 say they take no equity, and 1 has applications open.
Bayer-backed lab and office space in North Cambridge, listed among LabCentral's sites, for life science startups from pre-seed to Series A. Residents get Bayer mentoring and links to its R&D, deal and investment teams.
Funding not published · equity not published
Breakthrough to Scale is LearnLaunch's 10-week hybrid edtech accelerator in Boston for companies with a product and early revenue. It invests on acceptance for about 5 to 6% equity and charges no programme fees.
Funding not published · equity not published
MassChallenge runs equity-free, no-fee accelerators from Boston. Its US Traction programmes run themed hybrid cohorts with events in Boston and Dallas, such as Healthcare & Life Sciences and Security & Resiliency.
Funding not published · equity-free
A free, equity-free programme run through Nucleate's local chapters that helps scientific trainees form biotech companies around their research. Chapters operate in the US, Europe, Israel, Canada and Australia.
Funding not published · equity-free
We list 4 programmes: Bayer Co.Lab, LearnLaunch Accelerator, MassChallenge and Nucleate Activator. Each listing links to the programme's own pages and shows the day we last verified it.
2 of the 4 say they take no equity: MassChallenge and Nucleate Activator. 2 do not publish their equity terms.
Applications are open for Nucleate Activator (closes 20 October 2026). The deadlines page lists every date we track.
Boston (3) and Cambridge (1). Delivery varies: each listing says whether the programme runs in person, remotely or both.
Send us your dates and terms and we will publish them with a link to your own pages.